Session 4: AML & ALL
Tracks
TRACK A
| Saturday, May 17, 2025 |
| 8:30 AM - 10:15 AM |
Speaker
Dr. Naval G. Daver
Associate Professor, Department of Leukemia
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Novel Therapies in AML
8:30 AM - 9:10 AM
Dr. Murtadha Alkhabori
Senior Consultant
Sultan Qaboos University Hospital
Updates in ALL
9:10 AM - 9:35 AM
Dr. Wafa Mohammed
Clinical Fellow
NCCCR - Qatar
Challenging cases when using Blinatumab
9:35 AM - 9:55 AM
Abdul Rashid Shah
Senior consultant Hematology and Bone Marrow Transplantation
NCCCR- Hamad Medical Corporation
Hematopoietic stem cell Transplantation in Acute Leukemias in the Era of Novel therapies- An update
9:55 AM - 10:15 AM
